About Us

Aramune Technologies Ltd (ATL) is developing an entirely disruptive approach to infection prevention in livestock, companion animals and humans.

ATL’s unique approach targets the host's immune system (not the infectious organism) thereby avoiding the development of AMR (anti-microbial resistance). This is achieved by modulating an animal's natural immunity thus helping it to combat infection naturally. Our platform technology has many potential applications, but within ATL’s first target market (the animal feed sector) our approach is unique and potentially game-changing.

Modern farming systems aim to produce the highest quality food at maximum volume and lowest cost. To achieve these objectives farmers actively manage the health and wellbeing of livestock to reduce disease. Employing modern husbandry techniques, farmers can prevent many diseases and infections that would otherwise cause distress to their animals and compromise the commercial viability of their herd or flock.

Enhancing the health of livestock and the environment

Aramune  has proven to have consistent actions across multiple immune cell types, and across many species. Prior treatment of an experimental animal model with Aramune  effectively prevents bacterial infection. Laboratory-scale isolation generates a compound which is :


Sourced and isolated from plants that we have exhaustively tested

Orally Available

Demonstrated to have activity in animals when dosed orally

Endotoxin free

Aramune is safe and is not associated with any of the adverse effects of endotoxin lipopolysaccharide

Biocompatible & Pollinator-friendly

Aramune is sustainably produced from a variety of plant sources (some are native wildflowers in the UK) that are also grown specifically as a resource for pollinator species such as bees and butterflies


Even when used at doses that are greater than 10 times its maximum activity, Aramune is not cytotoxic in animals or humans

Aramune Technologies Ltd (ATL) was incorporated in February 2021 as a Queen's University Belfast (QUB)  spin-out company. The intellectual property has been exclusively licensed by QUB to ATL. In addition, the company continues to develop new IP and know-how related to the commercial extraction of plant compounds and the field cultivation of ‘source’ plant species. 

Contact Us

Thank you for your interest in Aramune! If you have questions, comments, or would like to talk about our products and technology, please contact us and we’ll get back to you as soon as possible.

C/O Qubis Ltd, 63 University Road, Belfast, Northern Ireland, BT7 1NF

Boosts the host animal’s immune system and resistance to bacteria, reducing mortality and weight loss.

crossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram